Cresco Labs Reports $215 Million Net Loss For 2022
Cresco Labs (CSE: CL) saw its revenues in 2022 increase 3% over the prior year. The firm this morning reported
Read moreCresco Labs (CSE: CL) saw its revenues in 2022 increase 3% over the prior year. The firm this morning reported
Read moreCresco Labs (CSE: CL) appears to be monetizing the appointment of director Tarik Brooks, which occurred last year. Brooks is
Read moreOn August 17, Cresco Labs (CSE: CL) reported its second quarter financial results. The company announced revenues grew by $218
Read moreCresco Labs (CSE: CL) was the latest cannabis operator to report earnings this morning for the second quarter. Growth has
Read moreEarlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the bottom on the drawdown but
Read moreCresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia Care (CSE: CCHW). The two
Read moreOn May 18th, Cresco Labs (CSE: CL) reported its first quarter financial results. The company reported revenues of $214 million,
Read moreCresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million. This is a decrease from
Read moreAt the tail end of March, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many investors as the
Read moreOn March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many investors as the company put
Read more